System (Promega). The purified products were then sequenced directly on an automated sequencer (model 373 A; Applied Biosystems) and by using the Prism Ready Reaction Dye Deoxy Terminator Cycle Sequencing kit (Applied Biosystems).
A total of 37 340-bp fragments were compared with each other and with the prototype sequence reported by Sinclair et al. (12) . No sequences were identical to the prototype: all had an A-to-C change at position 248 and a G-to-A change at position 288. On the basis of the nucleotide at position 85 ( Fig.  1) we were able to divide the isolates into three groups: group 1 sequences had a T (6 patients), group 2 sequences had an A (7 patients), and group 3 sequences had a C (15 patients). We observed no sequence differences between initial and repeat BAL samples for any of the eight patients for whom BAL was repeated. This showed that during a given episode of PCP, a patient retained the same strain of P. carinii. Only one patient (Table 1 ) developed a second episode of PCP, which was due to failure of aerosol pentamidine prophylaxis. The two episodes occurred 7 months apart, and the P. carinii isolates were identical. This suggested that the recurrence was due either to reactivation of remnant organisms from the first episode or to de novo infection by the same strain.
Our comparative analysis indicated that nucleotide sequences of P. carinii from different patients may be different and suggested that there were three strains of P. carinii among the patients in this study. In addition, the sequences we observed were different from those described by Lee et al. (8), who did not find a C-to-A change at position 85 and an A-to-C change at position 248 in P. carinii isolates from American, Canadian, and Italian patients. This suggests that differences among P. carinii strains could reflect geographic origin. As shown in Table 1 , there was no relationship between the date of BAL, the hospital, and the P. carinii strain. Group to be overrepresented, but no statistical analysis was possible because of the small group sizes. The three mutations we detected on a 300-bp fragment point to a mutation rate of 1% and to the existence of conserved sequences.
To conclude this preliminary study, we are now sequencing a larger number of samples and others genes with sequence repeats.
